{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-010889","form_type":"8-K","ticker":"CATX","cik":"0000728387","company_name":"Perspective Therapeutics, Inc.","filed_at":"2024-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.840357+00:00","generated_at":"2026-06-04T03:04:31.974373+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Perspective Therapeutics extends asset purchase closing deadline to April 30, 2024","bullets":["Amendment No. 1 changes the Termination Date under the Asset Purchase Agreement from March 31, 2024 to April 30, 2024.","Agreement is with GT Medical Technologies for sale of assets by Isoray Medical, a wholly owned subsidiary of Perspective Therapeutics.","No other terms of the original December 7, 2023 Asset Purchase Agreement were modified."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-010889","json":"https://secwatch.observer/filing/0001437749-24-010889.json","markdown":"https://secwatch.observer/filing/0001437749-24-010889.md","text":"https://secwatch.observer/filing/0001437749-24-010889.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/728387/000143774924010889/0001437749-24-010889-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/728387/000143774924010889/isr20240403_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:04:31.974373+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b398ba41e5709127a5e93bafb60031dc300c504","claim":"Perspective Therapeutics, Inc. amended Amendment No. 1 to Asset Purchase Agreement with GT Medical Technologies, Inc. valued at Termination date extended from March 31, 2024 to April 30, 2024 (effective 2024-03-28).","evidence_excerpt":"On March 28, 2024, Perspective Therapeutics, Inc. (the “ Company ”), Isoray Medical, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Medical ”), and GT Medical Technologies, Inc., a Delaware corporation (“ GT Medical ”) entered into Amendment No. 1 to Asset Purchase Agreement (the “ Amendment ”), which amends the Asset Purchase Agreement entered into by and among the parties on December 7, 2023 (the “ Agreement ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924010889/0001437749-24-010889-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"GT Medical Technologies, Inc."},{"label":"Value","value":"Termination date extended from March 31, 2024 to April 30, 2024"},{"label":"Effective","value":"2024-03-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}